Paydirt
EL
Insider

Erick Lucera

Chief Financial Officer

Erick Lucera (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Dyne Therapeutics, Inc. (DYN). The largest single filing was $107K of DYN (5,727 sh × $18.64, as filed), executed Apr 1.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$107K
shares × price, as filed
Last traded
Apr 1
Filed Apr 3

Median ADV $59.6M across their filed names

Open performance
Volume by month
$107K$53K$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · sells $107K
Buys $0 Sells $107K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
DYN Dyne Therapeutics, Inc. DYN · 0 buys · 1 sell 1 filing
Recent filings
DYNSALE Dyne Therapeutics, Inc. View filing → $107K
5,727 sh × $18.64
Exec Apr 1
Filed Apr 3 · 5:30 PM ET